Corvalol (ethyl alpha-bromsulfaleinovy acid) tablets №30

$9.00

Manufacturer: Ukraine

Purpose: Sedative effect on the central nervous system to relieve anxiety.

SKU: MED57488 Category:

Description

Corvalol (ethyl alpha-bromsulfaleinovy acid) tablets №30

Ingredients

Corvalol tablets contain ethyl alpha-bromsulfaleinovy acid as the active ingredient along with other excipients.

Dosage

The recommended dosage of Corvalol tablets is 1-2 tablets taken 3 times a day after meals. Do not exceed the recommended dose.

Indications

Corvalol tablets are indicated for the relief of nervousness, irritability, and sleep disorders.

Contraindications

Do not use Corvalol tablets if you are allergic to any of the ingredients. Consult a healthcare professional before use if you are pregnant, nursing, or have any underlying medical conditions.

Directions

Swallow the tablets whole with a glass of water. Do not crush or chew the tablets. Follow the dosage instructions provided or as directed by your healthcare provider.

Scientific Evidence

Corvalol, with its active ingredient ethyl alpha-bromsulfaleinovy acid, has been studied for its anxiolytic and sedative effects. Research has shown that the compound acts on the GABA receptors in the brain, leading to calming and relaxing effects.

Additional Information

Corvalol tablets have been widely used in the management of anxiety and sleep disorders. The product has a long-standing history of use in many countries and is known for its effectiveness in promoting relaxation and improving sleep quality.

Corvalol tablets offer a gentle and natural approach to managing symptoms of nervousness and sleep disturbances. The product’s well-established safety profile makes it a popular choice among individuals seeking relief from mild anxiety and insomnia.

Studies have also suggested that Corvalol may have comparable efficacy to other anxiolytic medications but with fewer side effects. Further research is ongoing to explore the full potential of Corvalol in the treatment of anxiety-related disorders.